Results 111 to 120 of about 3,571 (163)

Serotonin Availability Shapes the Effects of Phenelzine on Inflammatory Response and Gene Expression in Macrophages. [PDF]

Cureus
Mahdianipur S, Maralani M, Mohammadi S, Khandoozi SR, Jaefari A, Davoodi H.   +5 more
europepmc   +1 more source

Reactive aldehyde species-mediated neuropathic pain in spinal cord injury: Mechanisms and therapeutic opportunities. [PDF]

Neural Regen Res
Stingel RL, Race NS, Shi R.
europepmc   +1 more source

Preventing relapse in patients with major depressive disorder after an effective acute course of electroconvulsive therapy. [PDF]

Australas Psychiatry
Song M, Launder NH, Phutane VH, Moss F, Keogh AM, Chong TWH.   +5 more
europepmc   +1 more source

The lung-gut-brain axis in non-small-cell lung cancer: a narrative review with a systematic search of three signaling pathways. [PDF]

Front Immunol
Fan Y, Du L, Luo Q, Mei T, Zhou A, Liu H, Khan MQ, Gao F, Dong J.   +8 more
europepmc   +1 more source

Antidepressants and Lung Toxicity: A Narrative Review. [PDF]

Cureus
Shooshtari AA, Jayaraman EA, Kesavan R, Sarva S, Manjunath S, Patel A.   +5 more
europepmc   +1 more source

Structural Principles of Covalent Flavin Modification in Oxidoreductases. [PDF]

Biochemistry
Tanner JJ.
europepmc   +1 more source

Correction to "The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents". [PDF]

Pharmacol Res Perspect
europepmc   +1 more source

Treating depression in dialysis patients: pharmacological and non-pharmacological approaches. [PDF]

Clin Kidney J
Cukor D, Cornelius C, Dahl K, Figueiredo D, Sousa H, Archey A, Kimmel PL.   +6 more
europepmc   +1 more source

Current perspectives on circadian regulation of mitochondrial dynamics in mood disorders and perioperative stress. [PDF]

Front Pharmacol
Verbal F, Rubilar N, Marileo AM, Fierro H, Ramirez-Molina OG, Pinto-Leon A, Yevénes GE, Fuentealba J, Panes-Fernández J.   +8 more
europepmc   +1 more source

Selegiline, a monoamine oxidase-B inhibitor as a modulator of metabolic reprogramming for cancer therapy: a review. [PDF]

Front Pharmacol
Jayachandran J, Nambidi S, Kondaveeti SB, Pathak S, Radhakrishnan A, Banerjee A, Dutta Roy AK.   +6 more
europepmc   +1 more source